The CB2 receptor and its role as a regulator of inflammation.
作者： Caroline Turcotte , Marie-Renée Blanchet , Michel Laviolette , Nicolas Flamand
DOI: 10.1007/S00018-016-2300-4
关键词:
摘要: … the CB 2 receptor have an exacerbated inflammatory phenotype. This suggests that therapeutic strategies aiming at modulating CB 2 … Herein, we review the pharmacology of the CB 2 …
springer.com
paperity.org参考文章(206)
Pierre Carayon, Jean Marchand, Danielle Dussossoy, Jean-Marie Derocq, Omar Jbilo, Annie Bord, Monsif Bouaboula, Sylvaine Galiègue, Paul Mondière, Géraldine Pénarier, Gérard Le Fur, Thierry Defrance, Pierre Casellas, Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation Blood. ,vol. 92, pp. 3605- 3615 ,(1998) , 10.1182/BLOOD.V92.10.3605
John Malysz, Anthony V. Daza, Karen Kage, George K. Grayson, Betty B. Yao, Michael D. Meyer, Murali Gopalakrishnan, Characterization of human cannabinoid CB2 receptor coupled to chimeric Gαqi5 and Gαqo5 proteins European Journal of Pharmacology. ,vol. 603, pp. 12- 21 ,(2009) , 10.1016/J.EJPHAR.2008.11.047
Rebecca H. Robinson, Joseph J. Meissler, Xiaoxuan Fan, Daohai Yu, Martin W. Adler, Toby K. Eisenstein, A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10 Journal of Neuroimmune Pharmacology. ,vol. 10, pp. 318- 332 ,(2015) , 10.1007/S11481-015-9611-3
Dirk G. Demuth, Areles Molleman, Cannabinoid signalling (review) Life Sciences. ,(2006) , 10.1016/J.LFS.2005.05.055
Jie Wen, Rachel Ribeiro, Mikiei Tanaka, Yumin Zhang, Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis. Neuropharmacology. ,vol. 99, pp. 196- 209 ,(2015) , 10.1016/J.NEUROPHARM.2015.07.010
Sumi Fong Lee, Catherine Newton, Raymond Widen, Herman Friedman, Thomas W. Klein, Downregulation of cannabinoid receptor 2 (CB2) messenger RNA expression during in vitro stimulation of murine splenocytes with lipopolysaccharide. Advances in Experimental Medicine and Biology. ,vol. 493, pp. 223- 228 ,(2002) , 10.1007/0-306-47611-8_26
Lamont Booker, Steven G Kinsey, Rehab A Abdullah, Jacqueline L Blankman, Jonathan Z Long, Cyrine Ezzili, Dale L Boger, Benjamin F Cravatt, Aron H Lichtman, The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in mice British Journal of Pharmacology. ,vol. 165, pp. 2485- 2496 ,(2012) , 10.1111/J.1476-5381.2011.01445.X
Yiangos Yiangou, Paul Facer, Pascal Durrenberger, Iain P Chessell, Alan Naylor, Chas Bountra, Richard R Banati, Praveen Anand, COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurology. ,vol. 6, pp. 12- 12 ,(2006) , 10.1186/1471-2377-6-12
F Comelli, G Giagnoni, I Bettoni, M Colleoni, B Costa, The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation British Journal of Pharmacology. ,vol. 152, pp. 787- 794 ,(2007) , 10.1038/SJ.BJP.0707425
Natalia Malek, Katarzyna Popiolek-Barczyk, Joanna Mika, Barbara Przewlocka, Katarzyna Starowicz, Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures Neural Plasticity. ,vol. 2015, pp. 130639- 130639 ,(2015) , 10.1155/2015/130639